Attached files
| file | filename |
|---|---|
| EX-10.25 - EXHIBIT 10.25 - ANI PHARMACEUTICALS INC | tm205343d1_ex10-25.htm |
| 10-K - FORM 10-K - ANI PHARMACEUTICALS INC | tm205343d1_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - ANI PHARMACEUTICALS INC | tm205343d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ANI PHARMACEUTICALS INC | tm205343d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ANI PHARMACEUTICALS INC | tm205343d1_ex31-1.htm |
| EX-21 - EXHIBIT 21 - ANI PHARMACEUTICALS INC | tm205343d1_ex21.htm |
| EX-10.27 - EXHIBIT 10.27 - ANI PHARMACEUTICALS INC | tm205343d1_ex10-27.htm |
| EX-10.26 - EXHIBIT 10.26 - ANI PHARMACEUTICALS INC | tm205343d1_ex10-26.htm |
| EX-10.24 - EXHIBIT 10.24 - ANI PHARMACEUTICALS INC | tm205343d1_ex10-24.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of ANI Pharmaceuticals, Inc. on Form S-3 (No. 333-218671) and on Form S-8 (Nos. 333-196518, 333-214416, and 333-218120) of our reports dated February 27, 2020, on our audits of the consolidated financial statements as of December 31, 2019 and 2018 and for each of the years in the three-year period ended December 31, 2019, and the effectiveness of ANI Pharmaceuticals, Inc. and Subsidiaries’ internal control over financial reporting as of December 31, 2019, which reports are included in this Annual Report on Form 10-K to be filed on or about February 27, 2020.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Iselin, New Jersey
February 27, 2020